Literature DB >> 2642997

Chronic intestinal pseudo-obstruction: diagnosis and treatment.

L J Colemont1, M Camilleri.   

Abstract

Chronic intestinal pseudo-obstruction is a rare syndrome characterized by recurrent episodes of small bowel obstruction without evidence of a structural obstructing lesion. The two pathophysiologic types of this motility disorder are myopathic and neuropathic. The latter may affect extrinsic or intrinsic neural control of gut motility. Diagnosis is based on (1) recognition of the clinical syndrome and exclusion of mechanical obstruction by endoscopy, radiologic studies, or laparotomy and (2) manometric studies of the stomach and small bowel. Full-thickness biopsy specimens for histologic analysis may not be essential for the diagnosis in the future. The goals of treatment are the restoration of normal gut peristalsis and the correction of nutritional deficiencies. Prokinetic medications, surgical excision in cases of localized disease, and parenteral nutrition are frequently necessary. Management is difficult because of the lack of efficacious medications, extension of the disease to other regions, and complications of central parenteral nutrition. Prokinetic agents, venting enterostomies for relief of symptoms, and enteral supplementation are being evaluated in this intractable and serious condition.

Entities:  

Mesh:

Year:  1989        PMID: 2642997     DOI: 10.1016/s0025-6196(12)65304-x

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  17 in total

1.  Chronic Intestinal Pseudo-obstruction.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-06

2.  Paraneoplastic chronic intestinal pseudoobstruction as a rare complication of bronchial carcinoid.

Authors:  A Gerl; M Storck; A Schalhorn; J Müller-Höcker; K W Jauch; F W Schildberg; W Wilmanns
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

Review 3.  Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting.

Authors:  H P Parkman; M Camilleri; G Farrugia; R W McCallum; A E Bharucha; E A Mayer; J F Tack; R Spiller; M Horowitz; A I Vinik; J J Galligan; P J Pasricha; B Kuo; L A Szarka; L Marciani; K Jones; C R Parrish; P Sandroni; T Abell; T Ordog; W Hasler; K L Koch; K Sanders; N J Norton; F Hamilton
Journal:  Neurogastroenterol Motil       Date:  2009-12-09       Impact factor: 3.598

4.  Autonomic dysfunction in chronic intestinal pseudo-obstruction.

Authors:  R K Khurana; M M Schuster
Journal:  Clin Auton Res       Date:  1998-12       Impact factor: 4.435

Review 5.  Gastroparesis: pathogenesis, diagnosis and management.

Authors:  William L Hasler
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-07-19       Impact factor: 46.802

6.  Pneumatosis cystoides intestinalis in intestinal pseudoobstruction. Resolution after therapy with metronidazole.

Authors:  P P Tak; C M Van Duinen; P Bun; F Eulderink; J Kreuning; H G Gooszen; C B Lamers
Journal:  Dig Dis Sci       Date:  1992-06       Impact factor: 3.199

7.  Autonomic dysfunction in patients with chronic intestinal pseudo-obstruction.

Authors:  M Camilleri; R K Balm; P A Low
Journal:  Clin Auton Res       Date:  1993-04       Impact factor: 4.435

8.  Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction.

Authors:  G N Verne; E Y Eaker; E Hardy; C A Sninsky
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

9.  Idiopathic autonomic denervation in eight patients presenting with functional gastrointestinal disease. A causal association?

Authors:  M Camilleri; R D Fealey
Journal:  Dig Dis Sci       Date:  1990-05       Impact factor: 3.199

10.  Effect of octreotide on gastrointestinal pressure profiles in health and in functional and organic gastrointestinal disorders.

Authors:  K Haruma; J A Wiste; M Camilleri
Journal:  Gut       Date:  1994-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.